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Background: The original method for determining endurance shuttle walk test (ESWT) speed
involves components that are time consuming for clinicians. We sought to determine: (i)
whether components described in the original method for determining ESWT speed held true
and; (ii) the agreement between speeds derived using the original method and that equivalent
to 85% of the peak speed achieved during the incremental shuttle walk test (ISWT).
Methods: Patients with chronic obstructive pulmonary disease (COPD) performed two ISWTs
and one ESWT on separate days, wearing a calibrated portable gas analysis unit. A retrospec-
tive analysis of these data allowed us to determine whether: (i) the peak rate of oxygen uptake
( _VO2peak) can be accurately estimated from the incremental shuttle walk distance (ISWD)
and; (ii) ESWTs performed at a speed derived using the original method elicited 85% of
_VO2peak. Agreement between walks speeds was determined using BlandeAltman analysis.
Results: Twenty-two participants (FEV1 48  13% predicted, age 66  8 yr) completed the
study. The _VO2peak estimated from the ISWD was less than that measured during the ISWT
(mean difference 4.4; 95% confidence interval (CI), 6.0 to 2.9 ml$ kg1$min1). The ESWT
and ISWT elicited similar _VO2peak (mean difference 0.2; 95% CI, 1.5 to 1.2 ml$kg1$min1).
The mean difference (limits of agreement) between ESWT speeds was 0.15 (0.34) km$h1.ysiotherapy, Curtin University, GPO Box U1987, Perth, Western Australia 6845, Australia. Tel.: þ61 8
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1666 K. Hill et al.Conclusions: Components of the original method for determining the ESWT speed did not hold
true in our sample. ESWT speed can be derived by calculating 85% of the peak speed achieved
during the ISWT.
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The endurance shuttle walk test (ESWT)1 is an assessment
of walking endurance that is appropriate for assessing the
response to interventions in people with chronic
obstructive pulmonary disease (COPD).2 Its popularity as
an outcome in clinical studies is increasing, largely as
a result of its superior responsiveness when compared
with other field based walking tests, such as the 6-min
walk test (6MWT)3,4 and the incremental shuttle walk test
(ISWT).1 The method for calculating the speed for the
ESWT, as described in the original publication,1 involves
four components. First, an ISWT is performed and the
distance walked (ISWD) is recorded. Second the ISWD is
entered into a regression equation to estimate an indi-
vidual’s peak rate of oxygen uptake ( _VO2peak). Third,
a value equivalent to 85% of the estimated _VO2peak is
calculated. Fourth, a walk speed corresponding to 85% of
the estimated _VO2peak is derived using a published figure
that relates walk speed to the rate of oxygen uptake.1
This four-component process can be time-consuming for
clinicians and the reliance on the published figure during
the final component may lead to imprecision when
determining the speed for this test.
We recently compared the cardiorespiratory responses
to the 6MWT, ISWT, ESWT with a ramp-based cycle ergo-
metry test.5 A secondary analysis of these data allowed us
to determine the extent to which the components
described in the original method for calculating an appro-
priate speed for the ESWT held true and whether the
process for deriving the speed for the ESWT could be
simplified. The specific aims for this study were to
determine:
1. Whether _VO2peak can be accurately derived from ISWD.
2. Whether the rate of oxygen uptake during the ESWTwas
equivalent to 85% of _VO2peak.
3. The agreement between ESWT speeds derived using the
original four-component process and that equivalent to
85% of the peak speed achieved during the ISWT.Methods
Patients with stable COPD were recruited from referrals to
pulmonary rehabilitation programs and respiratory medi-
cine clinics. Individuals were excluded if they had evidence
of a co-morbid condition that may have adversely affected
their capacity to complete field-based walking tests such as
severe lower back pain or required a gait aid or supple-
mental oxygen during exercise. As the American Thoracic
Society/American College of Chest Physicians statement on
cardiopulmonary exercise testing6 indicates that a decrease
in arterial oxygen saturation (SpO2) to  80%, whenaccompanied by symptoms and signs of severe hypoxaemia
is a criterion that clinicians should use to terminate an
exercise test, we chose to exclude any individual who
desaturated to this extent during any of the tests. Approval
was obtained from the Research Ethics Board at our facility
and written informed consent was obtained from every
participant. Age, gender, height and weight were recorded
and recent spirometric measures of lung function were
extracted from the medical notes. Data collection per-
taining to the main study5 was completed over four
assessment sessions, each separated by at least one day.
During a session, participants completed either two 6MWTs,
two ISWTs, two ESWTs or one incremental cycle ergometry
test wearing a calibrated portable gas analysis unit
(Cosmed, K4b,2 Italy). To meet the aims of the current
study, data were used for the test that yielded the best
ISWD and the first of the two ESWTs. The speed for the
ESWT was determined according to the method originally
described.1 Standard protocols were used for both tests,1,7
and participants were instructed to increase their walking
speed when they first lagged behind the pace dictated by
the audio-signal.5
Data analysis
Data analyses were performed using the Statistical Package
for Social Sciences (version 19.0, SPSS Inc., Chicago, IL,
USA) and data are expressed as mean  standard deviation
unless otherwise stated. We estimated _VO2peak using the
following published regression equation8:
Estimated _VO2peak

ml$kg1$min1

Z 4:19
þ ðISWD  0:025Þ
and determined if it was different from the _VO2peak
measured directly during the ISWT using a paired t-test.
Agreement between the estimated and measured _VO2peak
was examined using the methods described by
BlandeAltman.9
To determine the extent to which the rate of oxygen
uptake measured during the ESWT corresponded to 85% of
the _VO2peak achieved during the ISWT, we compared the
_VO2peak achieved during the two tests using a paired
t-test. Further, the pattern of change in the rate of oxygen
uptake between the ISWT and ESWT was compared by; (i)
grouping data into deciles of the total test duration using
a two-dimensional data transformation (Sigmaplot,
version 12.0) and, (ii) fitting a curve to the profile of the
mean data for each test. Data collected during the 90 s
warm-up that preceded the ESWT were excluded from
these analyses.
We determined whether the speed equivalent to 85% of
the peak speed achieved during the ISWT differed from that
derived using the original four-component process using
Figure 1 BlandeAltman plot demonstrating agreement
between _VO2peak estimated using the published regression
equation and _VO2peak directly measured during the ISWT.
Solid black line indicates bias (mean difference) of
4.4ml$kg1$min-1. Limits of agreement were not calculated as
the difference between the measures was systematic. The
dashed line indicates no difference between themeasures. Note
that 19 (86%) data points are located below the dashed line
indicating that the regression equation underestimated
_VO2peak for most participants.
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BlandeAltman.9
Sample size calculations
The results of this study arise from the retrospective
analyses of an existing dataset. Therefore, sample size
calculations were not undertaken to meet the specific aims
of this study. Nevertheless, our sample size yielded
adequate power (a Z 0.05, 1-b Z 0.8) to detect a differ-
ence in speeds for the ESWT (i.e. that equivalent to 85% of
the peak speed achieved during the ISWT and that derived
using the original four-component process) of
0.17  0.27 km$h1 (or 2.8 m$min1). This difference is the
smallest difference in pre-recorded speeds available for
the ESWT.
Results
Characteristics of the 22 participants (14 men) are sum-
marised in Table 1 and have been described in detail
elsewhere.5
The ISWD was 343  104 m (range 180e550 m). The
speed for the ESWT was 4.29  0.64 km$h1 (range
3.27e5.54 km$h1) and the time to symptom limitation was
378  298 s (range 115e1156 s).
Results addressing aim 1
The _VO2peak estimated using the ISWD was 12.8
 2.6 ml kg1$min1 and the _VO2peak measured during the
ISWT was 17.2  4.7 ml$kg1$min1. The mean difference
between these measures was 4.4 ml$kg1$min1 (95%
confidence interval (CI), 6.0 to 2.9 ml$kg1$min1).
The published regression equation underestimated _VO2peak
in 19 (86%) participants. Significant heteroscedasticity
was observed as the difference between estimated
and measured _VO2peak increased as _VO2peak increased
(slope Z 0.683; p Z 0.001) (Fig. 1).
Results addressing aim 2
The _VO2peak measured during the ESWT was 17.4
 4.4 ml kg1$min1. The difference between the _VO2peak
achieved during the ESWT and ISWT was not significant
(mean difference 0.2; 95% CI, 1.5 to 1.2 ml$kg1$min1).
The profiles of _VO2peak measured during the ISWT and
ESWT are shown in Fig. 2. The oxygen uptake at theTable 1 Characteristics of the participants.
Variable Mean  SD
Age (yr) 66  8
BMI (kg/m2) 27.2  5.5
Height (m) 1.63  0.10
Weight (kg) 71.9  13.6
FEV1 (L) 1.13  0.35
FEV1 % predicted 48.5  13.0
BMI: body mass index; FEV1: forced expiratory volume in 1 s.beginning of the ISWT was less than that observed for the
ESWT because the ISWT was initiated from a stationary
standing position, whereas, the ESWT commenced after
a 90 s warm-up walk and data collected during this warm-
up were excluded from the analyses. The increase in the
rate of oxygen uptake with increasing time during the ISWT
could be described by the following linear function:Figure 2 Change in _VO2 during the incremental shuttle walk
test (open circles) and endurance shuttle walk test (closed
circles) plotted using the functions reported in the text. Data
are mean  SEM. Dashed black line represents the mean value
equivalent to 85% of the _VO2peak estimated from the ISWD.
The grey box represents the 95% confidence interval around
this mean value. Of note, the _VO2peak achieved during the
ESWT exceeded 85% of the _VO2peak estimated during the
incremental shuttle walk test in every participant.
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Consistent with previous work that has explored the
cardiorespiratory responses to a constant power test,10 the
increase in the rate of oxygen uptake with increasing time
during the ESWT could be described by the following three-
parameter single exponential function:
_VO2Z 9:90 þ

7:29  1 e0:62t; tZtimeðminÞ
During the ESWT, every participant exceeded 85% of the
_VO2peak estimated from the ISWD. Of note, in Fig. 2, the
shaded area, which indicates the 95% CI for values equiv-
alent to 85% of _VO2peak estimated using the ISWD, was
achieved within the first 0.5  0.5 min of the ESWT.
Results addressing aim 3
The speed equivalent to 85% of the peak speed achieved
during the ISWT was 4.44  0.67 km$h1 (range
3.09e5.69 km$h1). The mean difference between this
speed and that derived using the original method was
0.15 km$h1 (95% CI, 0.07e0.22 km$h1). The two methods
resulted in identical speeds for 8 (36%) participants and
a difference of one speed (of those available for the ESWT)
in 14 (64%) participants (Fig. 3).
Discussion
This study explored whether the peak rate of oxygen
uptake ( _VO2peak) can be accurately estimated from the
ISWD and whether ESWTs performed at a speed derived
using the original four-component process elicited 85% of
_VO2peak. In addition, it determined whether a simplemean speed calculated for ESWT using the 
original and proposed new method  
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Figure 3 BlandeAltman plot demonstrating agreement
between the speed determined for the endurance shuttle walk
test (ESWT) using the original method and that equivalent to
85% of the peak speed achieved during the incremental shuttle
walk test (new method). Solid black line indicates bias (mean
difference) equal to 0.15 km$h1. Dashed lines represent limits
of agreement equal to 0.34 km$h1. The size of each point (and
the number written inside) represents the number of data
points with that x,y coordinate.process for calculating the speed for the ESWT produced
similar speeds as the original four-component process. An
important finding of this study was that the regression
equation used to derive _VO2peak from the ISWD resulted in
a significant underestimation of the directly measured
_VO2peak. Further, our data indicate that the _VO2peak
achieved during the ESWT approached the _VO2peak directly
measured during the ISWT thereby exceeding a value
equivalent to 85% of the _VO2peak estimated from the ISWD.
Nevertheless, on average, the speed for the ESWT derived
using the original four-component process resulted in
a desirable duration for time to symptom limitation of
between 4 and 7 min.11 Our data suggest that using 85% of
the peak walk speed achieved during the ISWT produced
similar speeds for the ESWT when compared with that
derived using the original four-component process. These
findings indicate that components of the original method
described to calculate the speed for the ESWT may not hold
true in patients with COPD and are unnecessary when
calculating the speed for the ESWT. We propose that the
speed for this test can be simply determined by calculating
85% of the peak speed achieved during the ISWT.
When determining the speed for the ESWT, VO2peak is
estimated in order to relate the intensity of the test to an
individual’s aerobic capacity1 and to achieve a baseline
endurance time within the responsive range.11 The equa-
tion published to estimate _VO2peak included ISWD as the
sole independent variable and _VO2peak measured during an
incremental symptom-limited treadmill test as the depen-
dent variable.8 Our data demonstrated that this equation
produced values that were significantly less than those
directly measured during the test. The reasons for this do
not appear to be related to differences in the samples
between the studies. That is, compared with our sample,
the participants in the original study had similar disease
severity (forced expiratory volume in 1 s; 1.1  0.4 L vs.
1.4  0.5 L) and functional impairment (ISWD; 343  104 m
vs. 375  137 m).8 Further, both studies used the same ISWT
protocol.8 However, in contrast with our study which
measured _VO2peak using a portable gas analysis system
during the ISWT, the original paper measured the _VO2peak
during a laboratory-based treadmill test.8 Compared to
ground walking with frequent turns back and forth around
a 10 m course, treadmill walking requires less energy and is
more efficient.1 When walking at similar speeds, these
differences produced a consistent tendency to walk for
longer on a treadmill compared with ground walking.1 The
reduced efficiency associated with ground walking around
a 10 m course is likely to have increased the rate of oxygen
uptake for any given ISWD when compared with measure-
ments made during treadmill walking. The weight of the
portable gas analysis unit worn by the participants in our
study would also have contributed a small amount to the
higher rate of oxygen uptake. We speculate these to be the
reasons why the published regression equation under-
estimated the measured _VO2peak achieved during the ISWT
in our sample.
The original paper describing the ESWT investigated the
appropriateness of treadmill walk speeds corresponding to
75%, 85% and 95% of the _VO2peak measured during
a symptom-limited incremental treadmill test.1 They
concluded that a speed corresponding to 85% of _VO2peakwas
Determining the speed for the endurance shuttle walk test 1669most appropriate as; (i) unlike the test performed at 95% of
_VO2peak, it did not provoke a similar response as the ISWT,
(ii) compared with the test performed at 75% of _VO2peak,
a smaller proportion of tests were terminated by the inves-
tigator as the patients reached the upper limit of 20min and,
(iii) the exercise times were of an appropriate duration (i.e.
10.2  2.5 min). In the original study, the _VO2peak elicited
whilst walking on a treadmill at this speed corresponded to
87  13% of _VO2peak.1 In contrast with this study which
evaluated responses during treadmillwalking,1wecompared
the _VO2peak achieved during the ESWT with that achieved
during an ISWT, both of which necessitated ground walking
around a10mcourse.Our data demonstrated that the rate of
oxygen uptake achieved during the ESWT, performed at
a speed derived using the original four-component process,
was similar to the _VO2peakmeasured during the ISWT. This is
consistent with previous data showing that patients with
COPD achieved a similar _VO2peak cycling at 85% of peak
power when compared with that measured during an incre-
mental cycle ergometry test.12 Fig. 2 demonstrates that, on
average, patients with COPD have achieved a rate of oxygen
uptake equivalent to 85% of the _VO2peak, estimated using
the published regression equation, within the first 0.5 min of
the ESWT. These data do not suggest that the speed chosen
for the ESWTwas inappropriate. In fact, the time to symptom
limitation measured in our study (378  298 s) is likely to be
highly responsive to change,11,13 and suggests that the speed
was close to 120% of the maximum sustainable walking
speed.13 Rather, these data simply highlight that an ESWT
performed at a speed derived using the original four-
component process will elicit a _VO2peak that exceeds 85%
of the _VO2peak estimated from the ISWD.
Our data demonstrate similarity between the speeds
derived for the ESWT using the original four-component
process and that calculated to be 85% of the peak speed
achieved during the ISWT. Of note, these two methods
differed, on average, by 0.15 km$h1 (i.e. 2.5 m$min1). An
increase in walking speed of this magnitude has the
potential to reduce the time to symptom limitation by
approximately 1 min.13 However, given that performance
improves with familiarisation by an average of 50e60 s,1,5
any reduction in time to symptom limitation reduction is
likely to be offset, at least in part, by repeating the test.
This suggests that the speed for the ESWT can be derived by
simply calculating 85% of the peak speed achieved during
the ISWT rather than completing a more complicated four-
component process.Limitations
The main limitation of this study was that we did not
measure the time to symptom limitation achieved during
the ESWT performed at a speed equivalent to 85% of the
peak speed achieved during the ISWT and further research
is needed in this area. Notwithstanding this, we estimated
the difference in time to symptom limitation during the
ESWT performed at this slightly faster speed using our
previously published data demonstrating the power-
endurance relationship during walking tasks in COPD.13 As
patients who use gait aids and supplemental oxygen were
excluded, it is possible that our results do not extend tothese sub-groups. Further, as the study sample was char-
acterised by moderate to severe COPD, it is unclear if our
results extend to individuals with mild or very severe
disease.
Conclusions
In a sample of participants with stable COPD, our data
suggest that the regression equation used to derive
_VO2peak from the ISWD resulted in a significant underesti-
mation of the directly measured value and that the
_VO2peak achieved during the ESWT exceeded a value
equivalent to 85% of the _VO2peak estimated from the ISWD.
Further, speeds equivalent to 85% of the peak walk speed
achieved during the ISWT were similar to that derived using
the original four-component process. Taken together, these
results suggest that components described in the original
method for determining the speed for the ESWT did not
hold true and are unnecessary. We propose that speeds for
the ESWT can be simply derived by calculating 85% of the
peak speed achieved during the ISWT.
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